about
The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide AnalogsViral quasispecies evolutionAssociation of preexisting drug-resistance mutations and treatment failure in hepatitis B patientsEstablishment of real time allele specific locked nucleic acid quantitative PCR for detection of HBV YIDD (ATT) mutation and evaluation of its applicationRapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader AssayTwo-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions presentEvaluation of intra-host variants of the entire hepatitis B virus genomeMolecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.Complex dynamics of hepatitis B virus resistance to adefovir.Therapeutic implications of hepatitis C virus resistance to antiviral drugs.Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.Long-term effects of lamivudine treatment in Japanese chronic hepatitis B patientsIn vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiEffects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation.Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapyLow-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatment.New developments in the treatment of chronic hepatitis B.Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).Hepatitis C variability, patterns of resistance, and impact on therapyConstruction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C.Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance.Intracellular levels of hepatitis B virus DNA and mutational patterns of the polymerase gene of hepatitis B virus in peripheral blood mononuclear cells of patients with lamivudine or telbivudine resistance.Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B.Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance.Substitution rtq267h of hepatitis B virus increases the weight of replication and Lamivudine resistance.Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic historyEvolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.Comparison of ligase detection reaction and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B.Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing.Easy-to-use phylogenetic analysis system for hepatitis B virus infection.Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis.
P2860
Q26781795-FA789177-7F09-4727-A758-C44EF8EB99A9Q27013917-7758BDAB-0B39-4299-B80F-0CB9192CED02Q28535003-5C5F1779-905B-4901-8EAA-D0B56F65C300Q28540245-DDC8C958-42A0-4381-94AC-753C7E4DA67EQ28548426-19CE8FD1-D59E-4475-8144-9B90B8DB6087Q33267067-6B275B57-8C47-4F1D-9C14-0A98E3E66C84Q34032030-88D989AC-A57E-48F1-AD48-1F92723F13C2Q34080966-502FF151-80B2-4881-AB0A-3A8BAFAA8C49Q34208672-921269AE-03DD-40E5-87F2-CEFCE09D43BBQ34409020-86FEB502-CABE-4DF0-BC7E-D17EE19F618AQ34489239-B0883D6B-6082-40BF-ADA3-3ED143137D6CQ35085989-41EF9FAF-2F3D-4488-9E81-6BD16F0E472BQ35785174-769C82C2-AA3C-481B-96CE-A8A3268A8868Q36293979-2753DB56-184F-44B3-97D7-3EDBD7363382Q36406952-9397E73F-C57B-4B46-B595-CC0EB8B3B077Q36502057-C0EF2FDC-47AC-4313-84B9-2513FD4428D2Q36505336-5DAEDB8E-737B-4F60-B62B-984F5BD4FE18Q36569744-05620E53-1622-4877-88EF-5A28856B07C0Q36597776-84E3F8A3-6778-4E97-9B5D-2A6D6111C76AQ36897030-E7DFD2B4-005A-4315-9C2E-9C4447D7D4BFQ36954038-59EFB9B4-9286-4A27-864B-EA7739CA4E2EQ37074608-3C602E2B-01C0-4DAC-9FAB-56F89046A899Q37099761-B065CBFB-9293-4EC8-8B3D-2853C4EDEAEEQ37122612-12B872F0-1ACB-4DA3-8DE1-64EF3CF09728Q38424625-9A6593C2-EDCB-4936-B376-A20AF23F9F70Q39576325-4A8775E1-E4C8-4F83-ABAC-58D15B7EB335Q39966153-D8B8FCDA-7E25-469F-AD5E-B5968874318BQ39988589-429A3478-786D-4EB6-A94B-8B0793126A6EQ41492511-E0C1C1E9-D08B-4E85-8A1C-C9752354E6A1Q42177495-5D9DAE9C-9FB0-4C11-B7A2-D2F579D3DCC1Q42247961-C916683D-2148-44D7-9EE8-F24734F322AEQ42248469-CBA071DB-A002-4818-8D1A-A0860E0F2012Q42609924-47B7DCB4-2CAD-4794-8238-C7D7B0C54552Q42910007-7D1270E6-92F4-4D04-B2F8-485869925DEDQ43141117-00FEFEB1-FD9D-4F38-A34F-1E7D902D2CF7Q44675493-FEF6A17D-D58D-4D99-928A-0E3BBFFE81CDQ45363705-77431AF0-F141-4DD6-950C-D229779A6C2FQ52653387-165DED8E-1818-4345-86EB-8B045689C4F1
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Dynamics of hepatitis B virus resistance to lamivudine.
@en
type
label
Dynamics of hepatitis B virus resistance to lamivudine.
@en
prefLabel
Dynamics of hepatitis B virus resistance to lamivudine.
@en
P2093
P2860
P50
P1433
P1476
Dynamics of hepatitis B virus resistance to lamivudine.
@en
P2093
Alexandre Soulier
Christophe Hézode
Coralie Pallier
Daniel Dhumeaux
Laurent Castéra
P2860
P304
P356
10.1128/JVI.80.2.643-653.2006
P407
P577
2006-01-01T00:00:00Z